In this bonus EM Cases podcast, The Stiell Sessions 2 - Update in Atrial Fibrillation, we have Dr. Ian Stiell discussing an update in Atrial Fibrillation 2014 management including the age-old question of rate control vs rhythm control, the new CHADS-65 algorithm for oral anticogulant therapy, the need to initiate anticoagulant therapy in the ED, the more aggressive use of the Ottawa Aggressive Protocol, the dangers of attempting to cardiovert unstable patients who are in permanent Atrial Fibrillation, the new 150 rule to help determine the likelihood of successful cardioversion and much more.
Published December 2014
Cite this podcast as: Helman, A, Stiell, I. The Stiell Sessions 2 - Update in Atrial Fibrillation 2014. Emergency Medicine Cases. December, 2014. https://emergencymedicinecases.com/episode-57-stiell-sessions-2-update-atrial-fibrillation-2014/. Accessed [date].
Link to Episode 20 on Atrial Fibrillation with Dr. Clare Atzema, Nazanin Meshkat & Bryan Au on the pearls, pitfalls, ins and outs of Atrial Fibrillation to 2012.
Dr. Stiell's blog post on the Canadian Cardiovascular Society CHADS-65 Risk Stratification Algorithm
Dr. Stiell's blog post on ED Treatment Algorithm for Anticoagulants in Atrial Fibrillation
Dr. Stiell's blog post on Unstable Patients with Atrial Fibrillation
Canadian Atrial Fibrillation Guidelines 2014 Full PDF
American Heart Association Atrial Fibrillation Guidelines 2014 Full PDF
AFFIRM trial on rate control vs rhythm control
JACC Finnish study on Thromboembolic Complication After Cardioversion of Acute Atrial Fibrillation that challenges the 48 hour safety rule
The Ottawa Aggressive Protocol for cardioversion of Atrial Fibrillation with Procainamide
Update 2015: A viewpoint article in the Canadian Journal of Cardiology by Stiell et al. on the safety of urgent cardioversion in recent onset atrial fibrillation and flutter, in light of the Finnish study. Abstract
Update 2015: Study in Annals of Emergency Medicine suggests that patients given a prescription for warfarin in the ED may have better rates of long-term anti-coagulation. Abstract
Update 2015: Patients with atrial fibrillation or flutter and an acute underlying medical illness may not benefit from rate or rhythm control....